ReP USP - Resultado da busca

Artigo de periodico
Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial (2017)
Mehta, Sanjay; Sastry, Bhagavatula Kutumba Srinivasa; Souza, Rogério; Torbicki, Adam; Ghofrani, Hossein-Ardeschir; Channick, Richard N.; Delcroix, Marion; Pulido, Tomás; Simonneau, Gérald; Wlodarczyk, John; Rubin, Lewis J.; Jansa, Pavel; Hunsche, Elke; Galiè, Nazzareno; Perchenet, Loïc; Sitbon, Olivier
Fonte: CHEST. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, QUALIDADE DE VIDA, FARMACOTERAPIA, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Sanjay et al. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. CHEST, v. 151, n. 1, p. 106-118, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2016.08.1473. Acesso em: 21 out. 2025.
APA
Mehta, S., Sastry, B. K. S., Souza, R., Torbicki, A., Ghofrani, H. -A., Channick, R. N., et al. (2017). Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. CHEST, 151( 1), 106-118. doi:10.1016/j.chest.2016.08.1473
NLM
Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani H-A, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial [Internet]. CHEST. 2017 ; 151( 1): 106-118.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.chest.2016.08.1473
Vancouver
Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani H-A, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial [Internet]. CHEST. 2017 ; 151( 1): 106-118.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.chest.2016.08.1473
Artigo de periodico
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension (2017)
Galiè, Nazzareno; Jansa, Pavel; Pulido, Tomás; Channick Richard N.; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Rubin Lewis J.; Sastry, B.K.S.; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam
Fonte: European Heart Journal. Unidade: FM
Assuntos: MORTALIDADE, CATETERISMO CARDÍACO, ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALIÈ, Nazzareno et al. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, v. 38, n. 15, p. 1147-1155, 2017Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehx025. Acesso em: 21 out. 2025.
APA
Galiè, N., Jansa, P., Pulido, T., Channick Richard N.,, Delcroix, M., Ghofrani, H. -A., et al. (2017). SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, 38( 15), 1147-1155. doi:10.1093/eurheartj/ehx025
NLM
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2025 out. 21 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Vancouver
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2025 out. 21 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Artigo de periodico
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN (2015)
Simonneau, Gérald; Channick, Richard N.; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomás; Sastry, B. K. S.; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam; Rubin, Lewis J.
Fonte: European respiratory journal. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, ESTUDOS DE COORTES, FÁRMACOS (SISTEMA RESPIRATÓRIO), ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONNEAU, Gérald et al. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, v. 46, n. 6, p. 1711-1720, 2015Tradução . . Disponível em: https://doi.org/10.1183/13993003.00364-2015. Acesso em: 21 out. 2025.
APA
Simonneau, G., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H. -A., Jansa, P., et al. (2015). Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, 46( 6), 1711-1720. doi:10.1183/13993003.00364-2015
NLM
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2025 out. 21 ] Available from: https://doi.org/10.1183/13993003.00364-2015
Vancouver
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2025 out. 21 ] Available from: https://doi.org/10.1183/13993003.00364-2015
Artigo de periodico
Effect of macitentan on hospitalizations: Results from the SERAPHIN trial (2015)
Channick, Richard N.; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Hunsche, Elke; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Pulido, Tomás; Rubin, Lewis J.; Sastry, B. K. S.; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério de; Torbicki, Adam; Galiè, Nazzareno
Fonte: JACC Heart failure. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, FÁRMACOS/SISTEMA RESPIRATÓRIO, HOSPITALIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHANNICK, Richard N. et al. Effect of macitentan on hospitalizations: Results from the SERAPHIN trial. JACC Heart failure, v. 3, n. 1, p. 1-8, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jchf.2014.07.013. Acesso em: 21 out. 2025.
APA
Channick, R. N., Delcroix, M., Ghofrani, H. -A., Hunsche, E., Jansa, P., Le Brun, F. -O., et al. (2015). Effect of macitentan on hospitalizations: Results from the SERAPHIN trial. JACC Heart failure, 3( 1), 1-8. doi:10.1016/j.jchf.2014.07.013
NLM
Channick RN, Delcroix M, Ghofrani H-A, Hunsche E, Jansa P, Le Brun F-O, Mehta S, Pulido T, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R de, Torbicki A, Galiè N. Effect of macitentan on hospitalizations: Results from the SERAPHIN trial [Internet]. JACC Heart failure. 2015 ; 3( 1): 1-8.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.jchf.2014.07.013
Vancouver
Channick RN, Delcroix M, Ghofrani H-A, Hunsche E, Jansa P, Le Brun F-O, Mehta S, Pulido T, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R de, Torbicki A, Galiè N. Effect of macitentan on hospitalizations: Results from the SERAPHIN trial [Internet]. JACC Heart failure. 2015 ; 3( 1): 1-8.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.jchf.2014.07.013
Artigo de periodico
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension (2013)
Pulido, Tomás; Adzerikho, Igor; Channick, Richard N.; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Jing, Zhi-Cheng; Le Brun, Franck-Olivier; Mehta, Sanjay; Mittelholzer, Camilla M.; Perchenet, Loïc; Sastry, B. K. S.; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam; Zeng, Xiaofeng; Rubin, Lewis J.; Simonneau, Gérald
Fonte: The New England Journal of Medicine. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR (MORTALIDADE), CATETERISMO CARDÍACO, CONDUTAS TERAPÊUTICAS, MEDICAMENTO (EFEITOS ADVERSOS), MÉTODO DUPLO-CEGO, PLACEBOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PULIDO, Tomás et al. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. The New England Journal of Medicine, v. 369, n. 9, p. 809-818, 2013Tradução . . Disponível em: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1213917. Acesso em: 21 out. 2025.
APA
Pulido, T., Adzerikho, I., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H. -A., et al. (2013). Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. The New England Journal of Medicine, 369( 9), 809-818. doi:10.1056/NEJMoa1213917
NLM
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Jing Z-C, Le Brun F-O, Mehta S, Mittelholzer CM, Perchenet L, Sastry BKS, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension [Internet]. The New England Journal of Medicine. 2013 ; 369( 9): 809-818.[citado 2025 out. 21 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1213917
Vancouver
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Jing Z-C, Le Brun F-O, Mehta S, Mittelholzer CM, Perchenet L, Sastry BKS, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension [Internet]. The New England Journal of Medicine. 2013 ; 369( 9): 809-818.[citado 2025 out. 21 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1213917
Artigo de periodico
Pulmonary arterial hypertension: bridging the present to the future (2012)
Humbert, Marc; Souza, Rogerio; Galiè, Nazzareno; McLaughlin, Vallerie; Simonneau, Gérald; Rubin, Lewis
Fonte: European respiratory review. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, ECOCARDIOGRAFIA DOPPLER, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUMBERT, Marc et al. Pulmonary arterial hypertension: bridging the present to the future. European respiratory review, v. 21, n. 126, p. 267-270, 2012Tradução . . Disponível em: https://doi.org/10.1183/09059180.00005312. Acesso em: 21 out. 2025.
APA
Humbert, M., Souza, R., Galiè, N., McLaughlin, V., Simonneau, G., & Rubin, L. (2012). Pulmonary arterial hypertension: bridging the present to the future. European respiratory review, 21( 126), 267-270. doi:10.1183/09059180.00005312
NLM
Humbert M, Souza R, Galiè N, McLaughlin V, Simonneau G, Rubin L. Pulmonary arterial hypertension: bridging the present to the future [Internet]. European respiratory review. 2012 ; 21( 126): 267-270.[citado 2025 out. 21 ] Available from: https://doi.org/10.1183/09059180.00005312
Vancouver
Humbert M, Souza R, Galiè N, McLaughlin V, Simonneau G, Rubin L. Pulmonary arterial hypertension: bridging the present to the future [Internet]. European respiratory review. 2012 ; 21( 126): 267-270.[citado 2025 out. 21 ] Available from: https://doi.org/10.1183/09059180.00005312

Unidades USP

ReP

Filtros

Autores

Assuntos

Título da fonte

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos